one

MIST

Biotech

Health Care

Pharma

Country

CA

Industry

Financials

Market Cap

Micro Cap

Num. Employees

39

IPO Date

May 9, 2019

Create Alert

MIST

Country

CA

Industry

Financials

Biotech

Health Care

+1

Create Alert

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. The company is headquartered in Montreal, Quebec and currently employs 39 full-time employees. The company went IPO on 2019-05-09. The firm is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent and short-acting calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The firm is developing etripamil for the treatment of arrhythmias with an indication to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.